The page is the record's research on the issuer — no analyst, no rating, no view. # Black Diamond Therapeutics, Inc. (NASDAQ: BDTX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Black Diamond Therapeutics, Inc., listed on NASDAQ under ticker BDTX, with ISIN US09203E1055. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US. Its security type is Corporate and its sector is 2836 Biological Products, (No Diagnostic Substances). Its segment and jurisdiction are not on the record. Its listing status is listed, not halted. ## The disclosure read The record holds 38 filings in the twelve months to 2026-11-08, across 17 filing days. The median gap between filing days is 16.0 days. The latest filing is dated 2026-09-21 and is of type directors_dealings, 48 days before the record date. The exchange median is 6.0 days of cadence gap, 52 filings, and 5.0 days of latency across 4359 issuers. The sector median is 5.5 days of cadence gap, 65.5 filings, and 4.0 days of latency across 176 issuers. By type, the record holds 19 directors_dealings, 7 regulatory_filing, 7 results, 3 agm_egm, 1 corporate_news and 1 prospectus. ## Auditor The auditor of record is PricewaterhouseCoopers LLP, located in Boston, Massachusetts. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client_categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001701541.json (identity.name) - https://mcp.us-cm-kg.ai/events/NASDAQ/BDTX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1701541/000170154126000009/bdtx-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/BDTX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/BDTX · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp